New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
This Week on NeurologyLive® — April 15, 2024
Paradigm Shift in Parkinson’s Disease Diagnosis
Pridopidine Maintains Effectiveness in Huntington Disease Without Antidopaminergic Medications
Episode 108: Advancing the Genetic Pool of Parkinson Disease
NeurologyLive® Friday 5 — April 12, 2024
FDA Issues Complete Response Letter for Apomorphine Infusion Device SPN-830 in Parkinson Disease Treatment